This Article Full Text Full Text (PDF) All Versions of this Article: 2008-0109TRv1 39/4/383    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Janssen, L. J. Search for Related Content PubMed PubMed Citation Articles by Janssen, L. J.

Isoprostanes and Lung Vascular Pathology

Firestone Institute for Respiratory Health, St. Joseph's Hospital, and Department of Medicine, McMaster University, Hamilton, Ontario, Canada

Correspondence and requests for reprints should be addressed to L. J. Janssen, L-314, St. Joseph's Hospital, 50 Charlton Ave. East, Hamilton, ON, L8N 4A6 Canada. E-mail: janssenl{at}mcmaster.ca

Isoprostanes are products of peroxidative attack of membrane lipids. As such, they accumulate to substantial levels in conditions of oxidative stress, including many pulmonary vascular diseases such as acute lung injury and pulmonary hypertension, and are increasingly being used as indicators of disease state and severity. However, our group and others have hypothesized that they are more than inert markers, but may also act as signal transduction molecules. As isomers of prostaglandins, they can exert powerful biological effects on many lung cell types through actions on prostanoid receptors. In this review, we collect many lines of evidence that point to causal roles for the isoprostanes in those disease states.

Key Words: isoprostanes • acute lung injury • pulmonary hypertension • thromboxane receptors

CLINICAL RELEVANCE We first summarize the powerful biological actions of isoprostanes ("markers" of oxidative stress) on every lung cell type, then relate these findings to lung pathophysiology (pulmonary arterial hypertension and acute lung injury).

 

This article has been cited by other articles:

				E. Delannoy, A. Courtois, V. Freund-Michel, V. Leblais, R. Marthan, and B. Muller Hypoxia-induced hyperreactivity of pulmonary arteries: role of cyclooxygenase-2, isoprostanes, and thromboxane receptors Cardiovasc Res, September 16, 2009; (2009) cvp292v2. [Abstract] [Full Text] [PDF]

				P. A. Singleton, S. Chatchavalvanich, P. Fu, J. Xing, A. A. Birukova, J. A. Fortune, A. M. Klibanov, J. G. N. Garcia, and K. G. Birukov Akt-Mediated Transactivation of the S1P1 Receptor in Caveolin-Enriched Microdomains Regulates Endothelial Barrier Enhancement by Oxidized Phospholipids Circ. Res., April 24, 2009; 104(8): 978 - 986. [Abstract] [Full Text] [PDF]